Hindustan Bio Sciences Ltd (BSE: 532041) is a Hyderabad, Telangana-based company in the Biological Products industry. With a market capitalisation of ₹7 Cr, it ranks #5,207 by market cap among the 6,137 Indian listed companies on FinBizNet, and #5 of 5 in Biological Products. At ₹6.90 (as of 25 Oct 2026), the share price is 30.4% below its 52-week high of ₹9.92 and 38.0% above its 52-week low of ₹5.00. The share price is down 18.7% over one year and down 4.2% over three months.
| Current Price | ₹6.90 |
|---|---|
| Market Cap | ₹7 Cr |
| BSE Code | 532041 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology |
| Sub-Industry | Biotechnology > Biological Products |
| P/E Ratio | -86.3 |
| Return on Equity | -9.12% |
| Return on Assets | -2.35% |
| 52-Week Range | ₹5.00 – ₹9.92 |
| 1-Year Price Change | -18.7% |
| 3-Month Price Change | -4.2% |
| Beta (1Y) | 0.32 |
| Headquarters | Hyderabad, Telangana |
| Website | www.hindustanbiosciences.in |
Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India.
1. Pharmaceuticals-This segment manufactures and sells pharmaceutical products.
1. Trading of Drugs and Medicines-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Biocon Limited | ₹56,860 Cr | 120.9 | 1.15% | ₹4,336 Cr | -9.7% |
| Hester Biosciences Ltd | ₹1,905 Cr | 34.5 | 16.55% | ₹77 Cr | +19.5% |
| Zenotech Laboratories Ltd | ₹263 Cr | -238.3 | -1.12% | — | -20.3% |
| Transgene Biotek Ltd. | ₹19 Cr | -11.5 | -17.96% | ₹0 Cr | -39.2% |
| Hindustan Bio Sciences Ltd | ₹7 Cr | -86.3 | -9.12% | — | -18.7% |
Listed by market capitalisation. Ratios are shown for context only.
Hindustan Bio Sciences Ltd is trading at ₹6.90, with a market capitalisation of ₹7 Cr.
Hindustan Bio Sciences Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology space (Biotechnology > Biological Products).
Hindustan Bio Sciences Ltd has a P/E of -86.3 and a return on equity of -9.12%.
Hindustan Bio Sciences Ltd is listed on the BSE under the scrip code 532041.
Hindustan Bio Sciences Ltd's share price is down 18.7% over one year and down 4.2% over three months. Its 52-week range is ₹5.00 to ₹9.92.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.